This paper is concerned with the question of whether the coagulation factors in plasma and serum may react with each other before reacting with thromboplastin. The observations reported suggest an association between stable and labile factors.
thromboplastin. Normal human serum was used as the source of stable factor and normal human plasma after adsorption with calcium phosphate as the source of labile factor. It is recognized that these reagents may contain an unknown number of other factors, either described or to be described; the experiments are interpreted with this in mind. The clotting system was either platelet-poor oxalated human plasma or aged human plasma. The latter was used to test for labile factor activity. The lipid thromboplastin was a very dilute colloidal solution of rabbit brain phospholipid (0.1 mg./ml.) prepared as previously described. 0 Thromboplastic extract of acetone dehydrated rabbit brain (tissue thromboplastin) was prepared as described by Quick. 7 Centrifugation at 25,000 g. was carried out by means of a Sorvall SS-1 centrifuge. Protocols of representative experiments are presented in the tables. RESULTS When the stable factor (dilute serum) and the labile factor (adsorbed plasma) were mixed and allowed to react for 10 min. in the presence of calcium, and then lipid thromboplastin was added, high thromboplastin activity was noted almost immediately, within 30 sec. (table 1) . Coagulation times of 10 to 12 sec. were obtained on testing with normal plasma and calcium, contrasting with times of over 60 sec. when the preliminary reaction was omitted and the two factors were simply allowed to react with the lipid thromboplastin for 30 sec. Preliminary mixing of the lipid thromboplastin with either factor alone did not cause the rapid appearance of high activity which resulted from mixing the two conversion factors without the thromboplastin. Only minute traces of thrombin formed during the preliminary reaction. When aged plasma was used instead of fresh normal plasma in the final clotting mixture, it appeared that the preliminary reaction involved a great increase in activity of the labile factor. factor activity following preliminary reaction when lipid thromboplastin was used.
Recognizing that the sources of stable and labile factor may contain an unknown number of other factors, experiments were also performed with tissue thromboplastin, which is believed not to require most of these other factors. The reaction mixture of stable and labile factors showed increased labile factor activity when tested with aged plasma and tissue thromboplastin ( activity disappeared on removal of stable factor with calcium phosphate, leaving the labile factor activity initially present. The increase was not as large as that noted with lipid thromboplastin (table 2) .
When blood was allowed to clot after mixing with an equal volume of 0.1 M CaCl 2 , the serum showed greatly increased labile factor activity, on testing with tissue thromboplastin and aged plasma. Most of this labile factor activity remained on standing up to 24 hours at room temperature. The same phenomenon was noted when plasma was recalcified with twice the usual amount of calcium. This is shown in the following protocol. Increased activity was not observed using lipid thromboplastin. When the plasma after recalcification with increased calcium was mixed with tissue thromboplastin and centrifuged, much of the increased labile factor activity was found to be associated with the sediment of thromboplastin. This highly active sediment had no thrombin activity. No appreciable amount of labile factor activity was bound by the thromboplastic sediment when only the usual amount of calcium was used or when the original plasma, without recalcification, was tested in the relatively high dilution employed in these experiments. DESCUSSIOX The experiments on clotting in the presence of increased calcium were suggested by the work of Flynn and Standley, 4 indicating increased labile factor activity under these conditions. The increase in our experiments was large, roughly thirty-fold. It is hard to see how this could be due to exposure to thrombin, since conversion of prothrombin to thrombin is complete with the usual amount of calcium. As pointed out in the foregoing, a complex does form consisting of only thromboplastin and labile factor, but in the case of tissue thromboplastin relatively little of this factor is bound, and that only weakly. Therefore this complex is virtually impossible to demonstrate with tissue thromboplastin and human plasma because of the small amount of this factor in the human species, and its extreme instability; rabbit or bovine plasma must be employed instead. After recalcification of human plasma with increased calcium, the labile factor, instead of rapidly disappearing as usual, was apparently greatly increased in activity and was readily bound to the thromboplastin. This suggests that it was associated with stable factor, which does readily so bind.
As is frequently the case in this field, it is impossible to correlate with certainty the individual observations. The facts are: that a preliminary reaction in a system containing both labile and stable prothrombin conversion factors results in more rapid appearance of high activity in the conversion of prothrombin to thrombin on addition of lipid thromboplastin, that increased labile factor activity appears concomitantly, and that such activity is manifest with both lipid and tissue thromboplastin. Recognizing alternative explanations, it is believed that the simplest basis for the foregoing observations is a complex of the stable and labile prothrombin conversion factors. The evidence does not point to a single fixed constitution or configuration for such a complex but only the participation of the two conversion factors; the complex might well vary with conditions, such as concentration of calcium.
The complex of coagulation factors and thromboplastin, often called "plasma thromboplastin" which has the property of inducing almost immediate formation of thrombin, is rapidly inactivated in the plasma, like thrombin itself. Such provision for rapid inactivation of substances capable of causing immediate clotting is clearly a physiologic necessity. An intermediate complex such as the one indicated by the above data, on the other hand, appears to have sufficient stability so that it could circulate, bringing about not immediate coagulation but increased coagulability and tendency to thrombosis. SUMMARY A preliminary reaction in a system containing the stable and labile prothrombin conversion factors results in more rapid appearance of high activity in the conversion of prothrombin to thrombin on addition of lipid thromboplastin. The reaction involves an increase in the activity of labile factor. When coagulation is allowed to occur in the presence of increased calcium, a large increase in the activity of the labile factor results, together with greatly increased binding of this factor to tissue thromboplastin. These observations suggest the existence of a complex between the stable and the labile prothrombin conversion factors.
SUMMARIO IN INTEKLINGUA
Un reaction preliminar in un systema que contine le factores stabile e labile del conversion prothrombinic resulta in un accelerate apparition de alte activitate in le conversion de prothrombina in thrombina post addition de thromboplastina lipide. Le reaction involve un augmentate activitate del factor labile. Quando on lassa le coagulation occurrer in le presentia de augmentate concentrationes de calcium, il resulta un grande augmento in le activitate del factor labile insimul con un grandemente augmentate ligation de iste factor a thromboplastina tessutal. Iste observationes indica le existentia de un complexo inter le factores stabile e labile de conversion prothrombinic.
